Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
作者信息
Kim Yuli Y, Lluri Gentian, Haeffele Christiane, Daugherty Tami, Krasuski Richard A, Serfas John D, de Freitas R Andrew, Porlier Avaliese, Lubert Adam M, Wu Fred M, Valente Anne Marie, Krieger Eric V, Buber Jonathan, Rodriguez Fred H, Gaignard Scott, Saraf Anita, Hindes Morgan, Earing Michael G, Lewis Matthew J, Rosenbaum Marlon S, Zaidi Ali N, Hopkins Kali, Bradley Elisa A, Cedars Ari M, Ko Jong L, Franklin Wayne J, Frederickson Abby, Ginde Salil, Grewal Jasmine, Nyman Annique, Min Jungwon, Schluger Charlotte, Rand Elizabeth, Rosenthal Benjamin E, Hilscher Moira, Rychik Jack, Hoteit Maarouf A
机构信息
Division of Cardiology, Hospital of the University of Pennsylvania, Perelman Center for Advanced Medicine, 2nd Floor E. Pavilion, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
出版信息
Eur Heart J. 2024 Apr 21;45(16):1477-1480. doi: 10.1093/eurheartj/ehad788.
Abstract
摘要
相似文献
1
Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.Fontan手术后幸存者中的肝细胞癌：一项病例对照研究。
Eur Heart J. 2024 Apr 21;45(16):1477-1480. doi: 10.1093/eurheartj/ehad788.
2
Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.Fontan手术围手术期幸存者中肝硬化和肝细胞癌的预测因素。
Heart. 2023 Jan 27;109(4):276-282. doi: 10.1136/heartjnl-2022-320940.
3
Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series.Fontan手术后的肝细胞癌：多中心病例系列
Circulation. 2018 Aug 14;138(7):746-748. doi: 10.1161/CIRCULATIONAHA.117.032717.
4
A liver mass post-Fontan operation.Fontan手术后的肝脏肿块。
QJM. 2014 Jul;107(7):571-2. doi: 10.1093/qjmed/hcu020. Epub 2014 Mar 11.
5
HEPATOCELLULAR CARCINOMA WITH CARDIAC CIRRHOSIS AFTER THE FONTAN PROCEDURE.Fontan手术后出现心脏肝硬化的肝细胞癌
Gastroenterol Nurs. 2018 Jan/Feb;41(1):68-71. doi: 10.1097/SGA.0000000000000350.
6
Surveillance for liver complications after the Fontan procedure.Fontan手术后肝脏并发症的监测。
Congenit Heart Dis. 2017 Mar;12(2):124-132. doi: 10.1111/chd.12446. Epub 2017 Jan 31.
7
Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.Fontan手术患者肝脏结节的患病率、特征及预测因素：VALDIG Fonliver前瞻性队列研究
J Hepatol. 2020 Apr;72(4):702-710. doi: 10.1016/j.jhep.2019.10.027. Epub 2019 Nov 11.
8
Liver disease secondary to congenital heart disease in children.儿童先天性心脏病继发肝脏疾病。
Expert Rev Gastroenterol Hepatol. 2019 Jul;13(7):651-666. doi: 10.1080/17474124.2019.1621746. Epub 2019 May 26.
9
Hepatocellular carcinoma in two patients with cardiac cirrhosis.两例伴有心脏肝硬化的肝细胞癌患者。
Eur J Gastroenterol Hepatol. 2010 Jul;22(7):889-91. doi: 10.1097/MEG.0b013e32832e2bec.
10
Fontan-Associated Liver Disease: A Review.Fontan 相关肝疾病：综述。
Ann Hepatol. 2018 Mar 1;17(2):192-204. doi: 10.5604/01.3001.0010.8634.
引用本文的文献
1
Evaluation of red cell distribution width-to-platelet ratio and other laboratory markers in staging Fontan-associated liver disease.评估红细胞分布宽度与血小板比值及其他实验室指标在法洛四联症相关肝病分期中的作用
Kardiochir Torakochirurgia Pol. 2025 Jun 25;22(2):88-93. doi: 10.5114/kitp.2025.152440. eCollection 2025 Jun.
2
Hepatocellular carcinoma in Fontan-associated liver disease.Fontan相关肝病中的肝细胞癌
Ann Gastroenterol. 2025 Mar-Apr;38(2):133-142. doi: 10.20524/aog.2025.0948. Epub 2025 Feb 26.
3
Risk of malignancy in adult patients with congenital heart disease: a clinical practice review.成人先天性心脏病患者的恶性肿瘤风险：一项临床实践综述
Cardiovasc Diagn Ther. 2025 Feb 28;15(1):195-206. doi: 10.21037/cdt-24-388. Epub 2025 Feb 25.
4
Fontan-Associated Liver Disease.Fontan相关肝病
Semin Liver Dis. 2025 Mar;45(1):114-128. doi: 10.1055/a-2556-4897. Epub 2025 Mar 13.
5
Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation.Fontan手术后肝细胞癌的特征与生存结局
JACC Adv. 2025 Apr;4(4):101646. doi: 10.1016/j.jacadv.2025.101646. Epub 2025 Mar 12.
6
Comprehensive Multiomic Analysis Reveals Metabolic Reprogramming Underlying Human Fontan-Associated Liver Disease.综合多组学分析揭示人类Fontan相关肝病背后的代谢重编程。
J Am Heart Assoc. 2025 Mar 18;14(6):e039201. doi: 10.1161/JAHA.124.039201. Epub 2025 Mar 7.
7
Liver Imaging in Fontan Patients: How Does Ultrasound Compare to Cross-Sectional Imaging?Fontan 患者的肝脏成像：超声与断层成像相比如何？
JACC Adv. 2024 Oct 23;3(11):101357. doi: 10.1016/j.jacadv.2024.101357. eCollection 2024 Nov.
本文引用的文献
1
Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation.Fontan手术围手术期幸存者中肝硬化和肝细胞癌的预测因素。
Heart. 2023 Jan 27;109(4):276-282. doi: 10.1136/heartjnl-2022-320940.
2
Incidence, Predictors, and Mortality in Patients With Liver Cancer After Fontan Operation.法乐四联症术后肝癌患者的发病率、预测因素和死亡率。
J Am Heart Assoc. 2021 Feb 16;10(4):e016617. doi: 10.1161/JAHA.120.016617. Epub 2021 Feb 4.
3
Hepatocellular Carcinoma After Fontan Operation: Multicenter Case Series.Fontan手术后的肝细胞癌：多中心病例系列
Circulation. 2018 Aug 14;138(7):746-748. doi: 10.1161/CIRCULATIONAHA.117.032717.
4
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
5
Hepatic Fibrosis Is Universal Following Fontan Operation, and Severity is Associated With Time From Surgery: A Liver Biopsy and Hemodynamic Study.Fontan手术后肝纤维化普遍存在，其严重程度与手术时间相关：一项肝活检和血流动力学研究
J Am Heart Assoc. 2017 Apr 26;6(5):e004809. doi: 10.1161/JAHA.116.004809.
6
Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection.用于诊断慢性丙型肝炎病毒感染患者纤维化或肝硬化的血液检测。
Ann Intern Med. 2013 Sep 3;159(5):372. doi: 10.7326/0003-4819-159-5-201309030-00021.
7
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium.Fontan手术后肝脏的不稳定状态：多学科研讨会总结
Pediatr Cardiol. 2012 Oct;33(7):1001-12. doi: 10.1007/s00246-012-0315-7. Epub 2012 Apr 26.
8
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.开发一种简单的非侵入性指标以预测HIV/HCV合并感染患者的显著纤维化。
Hepatology. 2006 Jun;43(6):1317-25. doi: 10.1002/hep.21178.
Zotero 插件